Thomas Frazier joins the Autism Speaks Board of Directors

May 9, 2022
Tom Frazier's Headshot

Autism Speaks is pleased to announce the appointment of clinical psychologist and autism researcher Thomas W. Frazier, Ph.D., to the organization’s Board of Directors

Dr. Frazier is currently professor of psychology at John Carroll University and executive vice president for virtual and clinical care at Quadrant Biosciences, a molecular diagnostics company focused on neurological disorders and other health conditions. 

As a clinical psychologist, Dr. Frazier has been involved for more than 17 years in evaluation, treatment and research, with a focus on improving autism identification; new treatment approaches; creating and refining measures of autism symptoms; translational genetic studies; and quality of life in people with autism and their families. Dr. Frazier has published more than 130 peer-reviewed papers and numerous conference presentations.

From 2017-2020, Dr. Frazier served as chief science officer of Autism Speaks, where he was responsible for overseeing all science initiatives, including the MSSNG genomic research project and the Autism Care Network. His four-year tenure as chief science officer was a key driving force in Autism Speaks’ efforts to be a catalyst for life-enhancing research breakthroughs. 

His work as chief science officer will be continued by Andy Shih, Ph.D., who has been an integral member of the Autism Speaks science team for over 20 years and has led significant advancement towards the Autism Speaks mission while delivering high-impact scientific outcomes for the autism community. 

“With a career at the forefront of autism care and research, Dr. Frazier is uniquely suited to guide Autism Speaks on its mission to promote solutions, across the spectrum and throughout the life span, for the needs of individuals with autism and their families,” says Dr. Shih.

Dr. Frazier will also be the chair of the Medical and Science Advisory Committee, which provides continual guidance to Autism Speaks leadership on achieving our scientific mission of advancing research into causes and better interventions for autism spectrum disorder and related conditions.